Biohaven

Biohaven is a clinical-stage biopharmaceutical company with recognized leadership in both industry and academic settings. Our portfolio includes innovative late-stage candidates targeting neurological and neuropsychiatric disorders, including rare diseases. Our progress benefits from an entrepreneurial organizational structure, impressive drug development experience, and the confidence and support of top biopharmaceutical investors.